Anat Eldar‐Boock
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 5%
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 12
- Oncology 11
- Bone health and treatments 5
- Cancer Cells and Metastasis 4
- Co-authors
- Ronit Satchi‐Fainaro (29 shared papers)Anna Scomparin (7 shared papers)Dina Polyak (7 shared papers)Doron Shabat (3 shared papers)Galia Tiram (7 shared papers)Samer Gnaim (2 shared papers)Shiran Ferber (4 shared papers)Rachel Blau (3 shared papers)
- Journals
- Journal of Controlled Release (4 papers)The FASEB Journal (2 papers)Advanced Therapeutics (2 papers)Polymers for Advanced Technologies (2 papers)Biomaterials (2 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Anat Eldar‐Boock
34 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 109
- Biomaterials 617
- Molecular Medicine 90
- Pharmaceutical Science 108
- Biomedical Engineering 783
- Microbiology 93
Countries citing papers authored by Anat Eldar‐Boock
This map shows the geographic impact of Anat Eldar‐Boock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Eldar‐Boock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Eldar‐Boock more than expected).
Fields of papers citing papers by Anat Eldar‐Boock
This network shows the impact of papers produced by Anat Eldar‐Boock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Eldar‐Boock. The network helps show where Anat Eldar‐Boock may publish in the future.
Co-authors
The 25 scholars most cited alongside Anat Eldar‐Boock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 277 | |
| 2 | 2017 | 258 | |
| 3 | 2021 | 153 | |
| 4 | 2011 | 116 | |
| 5 | 2012 | 113 | |
| 6 | 2013 | 101 | |
| 7 | 2017 | 90 | |
| 8 | 2011 | 80 | |
| 9 | 2013 | 78 | |
| 10 | 2019 | 75 | |
| 11 | 2015 | 72 | |
| 12 | 2018 | 63 | |
| 13 | 2020 | 58 | |
| 14 | 2016 | 55 | |
| 15 | 2018 | 52 | |
| 16 | 2015 | 43 | |
| 17 | 2020 | 39 | |
| 18 | 2012 | 39 | |
| 19 | 2012 | 34 | |
| 20 | 2024 | 27 |
About Anat Eldar‐Boock
Anat Eldar‐Boock is a scholar working on Biomaterials, Oncology, Biomedical Engineering, Molecular Biology and Immunology and Allergy, having authored 35 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers), Bone health and treatments (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer Cells and Metastasis (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Biomaterials (617 citations), Molecular Medicine (90 citations), Pharmaceutical Science (108 citations), Biomedical Engineering (783 citations) and Microbiology (93 citations). Anat Eldar‐Boock has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Ronit Satchi‐Fainaro, Anna Scomparin, Dina Polyak, Doron Shabat, Galia Tiram, Samer Gnaim, Shiran Ferber, Rachel Blau, Ori Green and Keren Miller. Their work appears in journals such as Journal of Controlled Release, The FASEB Journal, Advanced Therapeutics, Polymers for Advanced Technologies and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.